TrovaGene, Inc.

TrovaGene, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. TrovaGene, Inc. is not a good value stock. TrovaGene, Inc. is not very popular among insiders. TrovaGene, Inc. is a mediocre stock to choose.
Log in to see more information.
Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses o...

News